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Abstract
This article summarizes the findings of consensus of the XI congress of the SEOEME. All of these conclusions 
are referring to the review articles responsible to the general rapporteurs in order to bringing up to date knowledge 
with regard to the use of implants in patients medically compromised and with special needs and, in the dental 
management of autism and cerebral palsy, in the dental treatment of patients with genetic and adquired haemato-
logical disorders, the dental implications of cardiovascular disease and hospital dentistry.
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Consensus report of group a: dental implants 
in patients with disabilities and with systemic 
diseases
The range of indications of dental implants have been 
very extended in recent times. One of the main factors 
responsible for this enlargement in the indications lies in 
the possibility of placing them in patients with systemic 
pathology. Very recently, many of these cases were re-
garded as absolute contraindications. The consensus 
conclusions about the placement of implants in patients 
with disabilities and systemic diseases are transcribed.
-Can be placed dental implants in psycho-physical disa-
bled patients? (1)
1) The comparison with studies involving other patient 
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populations without mental or physical impediments did 
not show statistically significant differences in terms of 
the failure rate recorded. 
2) The most important aspects in assessing the predict-
able aspects of treatment are alien to the intellectual 
capacity, such as the quantity and quality of bone, pos-
sibilities of maintenance of a proper oral hygiene, or 
control of parafunctions.
3) It is necessary to evaluate each case individually, 
following a strict surgical protocol and frequent check-
ups, as well as informing the patient’s caregivers about 
the importance of maintaining good oral hygiene and 
the absence of oral habits.
4) Implant therapy provides an increase in patient self-
esteem from an aesthetic point of view as well as in 
their quality of life, reduced by other diseases.
5) More studies with bigger sample and further follow-
ups should be carried out, with detailed information 
about the systemic condition of each patient, the pres-
ence of parafunctions, hygiene and placement of the 
implants. Although more experience is needed, implant 
rehabilitation can be now considered a suitable option in 
people with disabilities.
-Which are the contraindications to put dental implants 
in medically compromised patients? (2)
1) The evidence level of implant failures in medically 
compromised patients is limited due to the short number 
of controlled randomised studies. In geriatric medically 
compromised patients (70 years and over), with control-
led systemic diseases, should not be considered as a risk 
factor for dental implants failure subjected to prosthetic 
charge.
2) It does not seem to exist correlation between the lack 
of osseointegration of dental implants and patients with 
cardiovascular disease.
3) Head and neck radiotherapy could be responsible in 
the reduction of the success rate of dental implants when 
it is administered in doses exceeding 50 Gy.
4) The consumption of tobacco seems to be a factor as-
sociated with the increase in the loss of dental implants 
(failure rate 2.5-2.6), although, it is not a matter without 
controversy.
5) The risk of an increase in failures in diabetic patients 
seems to be relatively higher, but the risk of augmenting 
the failure rate are reduced if there is control of dia-
betes, antibiotic prophylaxis protocol and aseptic tech-
niques with chlorhexidine.
6) Osteoporosis may not be a contraindication for the 
placement of dental implants. The treatment with intra-
venous bisphosphonates present bigger incidence of risk 
of suffering osteonecrosis. The consumption of oral bi-
phosphonates by patients who suffer from osteoporosis 
seems to be a partial contraindication for the treatment 
with dental implants.
Consensus report of group b: dental manage-
ment of patients with autism and cerebral palsy
-What aspects are considered in reaching the dental 
management of patients with Autism Spectrum Disor-
ders (ASD)? (3)
1) Usually, patients diagnosed with autism disorder are 
significantly less cooperative than those diagnosed with 
Asperger’s syndrome and Pervasive Development Dis-
order. When older is a patient, higher his or her the co-
operation will be. Patients diagnosed with intellectual 
disability, cerebral paralysis, self-mutilation, or Pica 
disorder have a higher probability of poor cooperation 
as opposed to patients without these associated patholo-
gies.
2) There is no protocol for behavior management appli-
cable to all patients. It is recommend that this informa-
tion is gathered in a preliminary interview first contact 
with the parents/guardians of the patient.
3) There is no one system applicable to all patients di-
agnosed with Autism Spectrum Disorders. The most 
frequently used are: visual pedagogy, behavioural tech-
niques, behaviour modification techniques, physical fo-
cus techniques, and sometime pharmacological behav-
ior management techniques.
4) Patients with ASD do not present any specific dental 
characteristic in the soft or hard tissues, but… 
a. Some authors even reported a lower prevalence of 
caries. 
b. Bruxism is present in between 20 and 60%. 
c. Gingivo-periodontal pathology is more prevalent in 
these patients (differences are explained by the poorer 
levels of oral hygiene). 
d. The presence of adverse effects on the oral cavity 
from medicines have also been described, particularly 
hyposalivation, oral ulcers, delayed scarring or gingival 
enlargement.
-Which are the features of the dental treatment of pa-
tients with cerebral palsy compared with those without 
it? (4)
1) These patients have a higher rate of caries and bacte-
rial plaque in deciduous and permanent teeth compared 
to the general population.  The factors are related to:
a. Difficulty on controlling oral hygiene. 
b. The soft diet they follow. 
c. Difficulties in chewing and swallowing.
2) The periodontal status is related to an increased fre-
quency of gingival hypertrophy, as a consecuence from 
the decreased mechanical action of crushing food, and 
with the consumption of antiepileptic drugs.
3) These patients have a greater presence of hypoplasia 
and injuries to upper front teeth, due to the increase in 
falls caused by lack of motor control. And a high per-
centage of bruxism, (40-70% of cases), primarily affect-
ing the teeth of the upper jaw and the lower molars and 
premolars.
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4) The most common malocclusion is Class II with open 
bite and overjet due to the muscular hyperextension of 
the head which causes stretching of the oral soft tissues 
that contributes to mandibular retrognathia and vertical 
growth, causing molars to over-erupt and favoring low 
tongue position.
5) The drooling is attributed to poor coordination dur-
ing the voluntary phase of swallowing.
6) A significant proportion of patients with cerebral pal-
sy have to be treated using techniques of moderate-deep 
sedation or general anesthesia.
Consensus report of group c: dental manage-
ment of patients with genetic and acquired he-
matological diseases
-What attitude should be taken with the bleeding disor-
ders in the dental office? (5)
1) In the congenital / hereditary and acquired bleed-
ing disorders, substitution treatment, associated with 
preventive and local hemostasis strategies, are usually 
enough to control the complications that may arise.
2) The systematic care for these patients may include:
a. Clinical history.
b. Consultation to the specialist (hematologist / in-
ternist) if applicable. 
c. Considering the style of treatment (ambulatory, outpa-
tient sedation or under general anesthesia), where doing 
it and if there is possibility to do it all in one session. 
d. Prevent nerve block anesthesia techniques, (in par-
ticular the inferior alveolar) if feasible.
e. In odontopediatric treatments: 
i. Not overused the instrumental in pulpotomy and 
pulpectomies, 
ii. Do not invade gums (supragingival pediatric dental 
crown). 
iii. Cleaning carefully if there’s granulation tissue under 
the root.
f. In relation to aspiration: 
i. Support the nozzle on rollers or gauze and never di-
rectly on mucous.
ii. Using spit ejector suction instead of surgical suction 
for being less traumatic. 
g. According to the use of the rubber dam:
i. Produces gingival retraction and field isolation, 
ii. Reduces the possibility of injuring lips and mucous 
membranes. 
h. In orthodontic treatments, 
i. Bands, brackets and fixed maintainers, always ce-
mented in a supragingival way, 
i. When there are decays,  extractions are the last option, 
j. Application of topical hemostasis ways and local 
measures: 
i. Systemic and topical tranexamic acid, 
ii. Desmopressin,  
iii. Material to fill the socket: Surgicell, cellulose plugs, 
fibrin sponge,  microfibrillar collagen,  fibrin , cyanoacr-
ylate adhesive. 
iv. Antifibrinolytic rinses, 
k. Scheduled instruction until post-treatment revision.
l. Preventive and maintenance programs of oral hygiene.
-In the dental office, how can be changed the therapeu-
tic approach of antiaggregated and/or anticoagulated 
patients? (6)
1) Related to the Dental management in patients with 
classic antiplatelets treatment the material published in 
the Guidelines of the American College of Chest Phy-
sicians about perioperative management of antithrom-
botic therapy must be followed. Particullary:
a. In patients who are receiving ASA for the second-
ary prevention of cardiovascular disease and are having 
minor dental procedures, we suggest continuing ASA 
around the time of the procedure instead of stopping 
ASA 7 to 10 days before the procedure.
b. In patients at low risk for cardiovascular events who 
are receiving ASA therapy, we suggest stopping ASA 
7 to 10 days before surgery instead of continuation of 
ASA.
c. In patients with a coronary stent who are receiving 
dual antiplatelet therapy and require surgery, we recom-
mend deferring surgery for at least 6 weeks after place-
ment of a bare-metal stent and for at least 6 months after 
placement of a drug-eluting stent instead of undertak-
ing surgery within these time periods.
d. In patients who require surgery within 6 weeks of 
placement of a bare-metal stent or within 6 months of 
placement of a drug-eluting stent, we suggest continu-
ing dual antiplatelet therapy around the time of surgery 
instead of stopping dual antiplatelet therapy 7 to 10 days 
before surgery.
2) Related to the Dental management in patients with 
classic anticoagulants treatment: 
a. The studies recommend that in case of simple den-
tal extraction of one or two teeth (contiguous or adja-
cents), not removing the anticoagulant drug. We must 
control the drug s´ anticoagulant action with the INR, 
whose va-lue has to be done at least 72 previous hours 
to the dental extractions, although it s´ better if it s´ 
done 24 hours before. The INR ideal value for doing 
the dental extractions is established between 2 and 4, 
although it s´ widely accepted that the optimal value is 
in 2,5 because this value minimises the risk of bleed-
ing and thrombosis.
b. If the dental extraction will be complicated, flap and 
osteotomy is necessary or patients with multiple pathol-
ogies we can bridge anticoagulants with low molecular 
weight heparine, 2 or 3 days before dental surgery. With 
these patients local hemostatic actions must be used.
3) Related to the dental management in patients with 
new antiplatelets treatment:
It’s applied the same protocols as the normally used with 
Med Oral Patol Oral Cir Bucal. 2014 Sep 1;19 (5):e495-9.                                                                                                                                                      Consensus Report XI SEOEME Congress
e498
those patients who take the classic antiplatelet medica-
tion. Sometimes may be not effective and therefore there 
will be a need of a rescue therapy or other therapeutic 
measures, such as dialysis or gastric lavage.
4) Related to the dental management in patients with 
new anticoagulants treatment:
a. There are only a few studies about dental manage-
ment in patients under treatment with the new antico-
agulant drugs, although they also indicate the need of 
making clinic studies that support the protocols. 
b. Simple dental extraction and minor surgery have a low 
risk of bleeding, however the multiple dental extractions 
have a high risk of bleeding, for this we recommend the 
dental extraction no more than 3 teeth in the same surgi-
cal act and they will be contiguous or adjacents. 
c. With the new anticoagulant drugs (dabigatran, ri-
varoxaban, etc.) it would not be necessary removing its 
during the dental treatment, although, there are not any 
studies that support this particular way of acting. 
d. New anticoagulants (dabigatran, rivaroxaban and 
apixaban) have a reduced half life and in case of being 
necessary its removal, it will be done 24 hours before 
the surgical treatment. Its reintroduction must be done 
as soon as possible if there isn’t bleeding, normally rec-
ommending to do it 24 hours after surgical act. If there 
is a postoperative bleeding risk the reintroduction will 
be done after 2-3 days from surgery with normal dose. 
e. At the present, these drugs do not have effective an-
tidote known.
Consensus report of group d: the hospital den-
tistry as health resource in special patients
-What kind of patients could benefit from the hospital 
dental care? (7)
1) Using the ASA scoring system developed by the 
American Society of Anesthesiologists, In the case of 
ASA IV patients, dental treatment should be provided 
in the hospital setting in order to avoid complications. 
This group includes uncontrolled diabetes; patients with 
type II angina, patients visiting the dental office with 
oxygen therapy; individuals with myocardial infarction 
or stroke in the last 3 months; individuals with a blood 
pressure of over 200/100 mmHg; patients of very old 
age, excessive medication use, or the administration of 
immunosuppressors or anticoagulants. 
2) In patients at risk we must ensure good pain control 
and the use of premedication, sedation or general an-
esthesia techniques.
-What kind of dental patients have to be treated under 
general anesthesia in a hospital setting? (8)
1) Patients without underlying systemic diseases (with 
irrepressible fear, with large needs in a single session).
2) Handicapped Patients (with great difficulty of clini-
cal or behavioral management).
3) Special pediatric patients (patients with nursing bot-
tle caries, extensive rampant caries or severe medical 
problems).
4) Medically compromised patients (ASA IV patients).
Consensus report of group e: cardiovascular pa-
thology and dentistry
-Are there any evidence of association between the bac-
teremia of dental origin and bacterial endocarditis? (9)
1) Dental extraction is the procedure that carries the 
highest risk of bacteremia in terms of prevalence, du-
ration and magnitude. There is no conclusive evidence 
that gingival and periodontal health are contributing 
factors that predispose to the development of bacteremia 
in patients undergoing dental procedures, although it is 
likely that they are relevant to the onset of bacteremia 
when performing periodontal interventions. Activities 
of everyday living, such as chewing and toothbrushing, 
can also cause bacteremia and their clinical importance 
is based on the concept of “cumulative exposure to bac-
teremia”. As a result of dental treatment a small amount 
of patients contract bacterial endocarditis.
2) Apart from its possible implication in the onset of 
episodes of bacterial endocarditis, there has been in-
creasing interest in bacteremia of oral origin in the past 
two decades due to the major role it is considered to play 
in the progression of atherosclerosis and consequently 
in the occurrence of chronic diseases. It is imperative 
that molecular sequence-based approaches be validated 
and used in prospective trials to achieve a better under-
standing of the bacterial characteristics associated with 
bacteremia of oral origin.
3) Scientific evidence in the field of oral bacteremia has 
greatly influenced clinical practice guidelines on proph-
ylaxis against bacterial endocarditis of oral origin. The 
reduction of bacteremia, preventing the adherence of 
bacteria to the endocardium, is the main benefit of the 
use of prophylaxis. Over the past 50 years, prophylac-
tic regimens for the prevention of bacterial endocarditis 
secondary to dental procedures have been modified but 
remain consensus based. The indication for prophylaxis 
is now limited to patients with the highest risk of bac-
terial endocarditis undergoing the highest risk dental 
procedures. However, the National Institute for Clinical 
Excellence (NICE) of the United Kingdom has adopted 
a drastic stance in this respect, recommending the ces-
sation of antibiotic prophylaxis for bacterial endocardi-
tis in individuals undergoing dental procedures in the 
United Kingdom. Further research should be encour-
aged to determine the impact of this recommendation 
of the NICE guideline. In any way, from a legal point 
of view, it is recommended to follow clinical guidelines 
established in each country.
4) The conclusions reached by the NICE on the lack of ef-
ficacy of antiseptic prophylaxis for the prevention of bac-
teremia following dental procedures are based on a small 
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volume of published scientific evidence. At the present 
time, the controversies concerning the efficacy of anti-
biotic prophylaxis and the risk-benefit and cost-benefit 
relationships of antibiotic prophylaxis could justify con-
venience more extensively research on the recommended 
chlorhexidine regimens and new antiseptic protocols.
5) All Expert Committees on bacterial endocarditis pre-
vention agree on the premise that “Good oral hygiene and 
regular dental checkups are of particular importance for 
the prevention of bacterial endocarditis of oral origin”. 
-Is there scientific evidence about the relationship be-
tween the cardiovascular disease, metabolic syndrome 
and dental diseases? (10)
1) There is great variability among the studies that have 
explored the association between oral alterations and 
cardiovascular disease. Most authors reporting a mod-
erate association, without the firm scientific evidence 
needed to confirm a true causal relationship.
2) The confirmation of periodontal disease as an in-
dependent risk factor would result in more aggressive 
treatment of patients at a high risk of developing car-
diovascular disease. More solid scientific evidence is 
required in this respect, based on longitudinal studies 
with standardized measurements and prolonged follow-
up, controlling for other risk factors, and randomized 
studies of periodontal treatment.
3) A recent metaanalysis has revealed a clear associa-
tion between metabolic syndrome and periodontitis – 
the subjects with metabolic syndrome being almost 
twice as likely to develop periodontitis than the rest of 
the population.
4) The existing scientific evidence suggests that obesity, 
and particularly diabetes mellitus, could be related to an 
increased susceptibility to periodontitis. However, it is 
not clear whether periodontal treatment could improve 
the systemic conditions of such patients.
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